findmyKOL

Evan Lipson, MD

Enriched profile

Associate Professor of Oncology · Johns Hopkins University

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Baltimore, MD · Northeast · United StatesSpecialtyMedical OncologyFocusCancer Immunotherapy and Biomarkers+4
Active KOLEmergingfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Evan Lipson is Associate Professor of Oncology at Johns Hopkins University. OpenAlex indexes 373 publications with 22,120 citations (h-index 57); ClinicalTrials.gov lists 6 registered studies with this person as an investigator.

Data verified 16 Oct 2026

Overview

Updated 16 Oct 2026

Evan Lipson, MD, is Associate Professor of Oncology at Johns Hopkins University (Sidney Kimmel Comprehensive Cancer Center / Bloomberg-Kimmel Institute for Cancer Immunotherapy). The public record shows 373 publications with 22,120 citations (h-index 57), centered on Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, CAR-T cell therapy research. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 17 companies.

  • Most recent indexed publication: 2026 · Cancer immunology research
  • Top research focus: Cancer Immunotherapy and Biomarkers
  • 6 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 17 companies

Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Melanoma5 trialsBasal Cell Carcinoma3 trialsCarcinoma, Squamous Cell2 trialsCarcinoma, Merkel Cell2 trialsLung Cancer (NSCLC/SCLC)1 trialKidney Cancer / RCC1 trialSmall Cell Lung Carcinoma1 trial

Research focus

OpenAlex concept fingerprint
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesCAR-T cell therapy researchCutaneous Melanoma Detection and ManagementMelanoma and MAPK Pathways

Drugs & molecules

across trials, industry payments and publications
Libtayogeneric · CemiplimabClinical trials—Industry payments41Publications1Opdivogeneric · NivolumabClinical trials—Industry payments4Publications11Keytrudageneric · PembrolizumabClinical trials—Industry payments9Publications4Odomzogeneric · SonidegibClinical trials—Industry payments23Publications—Unloxcytgeneric · CosibelimabClinical trials—Industry payments14Publications—Aminolevulinic acidClinical trials—Industry payments7Publications—Braftovigeneric · EncorafenibClinical trials—Industry payments7Publications—Amtagvigeneric · LifileucelClinical trials—Industry payments2Publications—Carvyktigeneric · Ciltacabtagene autoleucelClinical trials—Industry payments1Publications—Erivedgegeneric · VismodegibClinical trials—Industry payments1Publications—Krazatigeneric · AdagrasibClinical trials—Industry payments1Publications—Lenvimageneric · LenvatinibClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Sun Pharmaceutical Industries Inc.Clinical trials—Industry payments44Regeneron Pharmaceuticals, Inc.Clinical trials—Industry payments38E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments33Merck Sharp & Dohme LLCClinical trials—Industry payments16Regeneron Healthcare Solutions, Inc.Clinical trials—Industry payments12Array Biopharma IncClinical trials—Industry payments7Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsClinical trials4Industry payments—Celgene CorporationClinical trials—Industry payments2Genzyme CorporationClinical trials—Industry payments2Iovance Biotherapeutics, Inc.Clinical trials—Industry payments2Janssen Scientific Affairs, LLCClinical trials—Industry payments2Merck Sharp & Dohme CorporationClinical trials—Industry payments2National Cancer Institute (NCI)Clinical trials2Industry payments—Sanofi-Aventis U.S. LLCClinical trials—Industry payments2Eisai Inc.Clinical trials—Industry payments1Genentech USA, Inc.Clinical trials—Industry payments1Gilead Sciences, Inc.Clinical trials—Industry payments1Janssen Biotech, Inc.Clinical trials—Industry payments1Novartis Pharmaceuticals CorporationClinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
373publications

Distinct works indexed by OpenAlex, matched via ORCID; 36 in PubMed.

22,120citations

Total citations across indexed works.

57h-index

Hirsch index (OpenAlex). i10-index 108.

Clinical & industry

trials, payments and federal funding
6clinical trials

Investigator role on registered studies.

View trials ↓
17companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 16 Oct 2026

Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:

All 6 trial records: search, sort and filter.Explore →

Industry payments

Updated 16 Oct 2026

17 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

All 33 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    57.1%
    Corticosteroid57.1%
    Hydrocortisone100%
    Part D<11 patients

  • Cancer & immunology

    42.9%
    Mitogen-activated protein kinase (MEK) inhibitors42.9%
    Mektovi100%
    Part D<11 patients
Where care is delivered (Part B)82.7% facility · 17.3% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Congress activity

Updated 16 Oct 2026

47 congress contributions (2014–2026) across AACR, ASCO, ASTRO, ESMO per OpenAlex. The most recent:

All 47 congress records: search, sort and filter.Explore →

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 16 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

All 36 publications: search, sort and filter.Explore →

Most-cited works

by citation count (OpenAlex)
  1. 01
    Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
    5,120 citations2014
    doi.org ↗
  2. 02
    Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
    2,208 citations2014
    doi.org ↗
  3. 03
    PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma
    1,246 citations2016
    doi.org ↗
  4. 04
    Evolutionary dynamics of cancer in response to targeted combination therapy
    647 citations2013
    doi.org ↗
  5. 05
    Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors
    644 citations2016
    doi.org ↗
All 373 cited works: search, sort and filter.Explore →

Network

Updated 16 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Janis M. Taube113Suzanne L. Topalian69Nicholas D. Socci62Julie E. Stein61Jarushka Naidoo57Kara M. Schenk55Julie R. Brahmer54John M. Kirkwood53Margaret K. Callahan49Drew M. Pardoll49Charlotte E. Ariyan46Travis J. Hollmann46Mark Yarchoan46Carl Campos45Claire Temple‐Oberle45Elizabeth McDonough45Maryam Pourmaleki45Thomas Brenn45Raymond Traweek45David S. Klimstra45Ingo K. Mellinghoff45Mianlei Zhang45Michael G. White45Yanyun Li45Jennifer A. Wargo45Billel Gasmi45Andrea Schietinger45Alex D. Corwin45Daniel A. Navarrete45Stephanie L. Goff45Caitlin J. Jones45Subhiksha Nandakumar45Fiona Ginty45Saad Nadeem45Mono Pirun45Zheng Zeng45F. Stephen Hodi44Elizabeth M. Jaffee42Yasser Ged41Paolo A. Ascierto40

Online presence

Updated 16 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/evan-lipson-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • X / Twitter

    x.com/evanlipson

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗

Mentions by others

where others cite or feature them
  • X / Twitter

    X (Twitter) handle @evanlipson

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →twitter.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 16 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Board Certified

    Medical Oncology, American Board of Internal Medicine

    2010
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
  • MD

    Mount Sinai School of Medicine (2005), graduated with distinction in research

    2005
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗

Editorial & leadership roles

journal and society appointments
  • Member

    American Society for Clinical Oncology (ASCO)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
  • Member

    Society for Melanoma Research

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
  • Member

    Society for Immunotherapy of Cancer (SITC)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
  • Member

    Eastern Cooperative Oncology Group (ECOG)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
  • Member

    International Immunosuppression & Transplant Skin Cancer Collaborative

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
  • Member

    European Society for Medical Oncology (ESMO)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗

Awards & honors

honors on the public record

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.